State-of-the-Art Sessions Wednesday
Wednesday, July 3, 11.00-12.00
SoA-13: New and old anticoagulants
- The role of the laboratory in treatment with new oral anticoagulants (NOACs)
Trevor Baglin (United Kingdom) - Optimisation of anticoagulant treatment in the elderly
Elaine Hylek (USA)
SoA-14: Microparticles
- Microparticles: key protagonists in venous and arterial thrombosis
Françoise Dignat-George (France) - Innovating in detection of microparticles and exocomes
Rienk Nieuwland (Netherlands)
SoA-15: Genetics: human and mice
- Novel mouse models for venous thrombosis research
Bart van Vlijmen (Netherlands) - Genetics of venous thrombosis
Pierre-Emmanuel Morange (France)
SoA-16: Women’s issues in bleeding and thrombosis
- Haemostatic disorders in women
Rezan Kadir (United Kingdom) - Thrombosis in women: what are the knowledge gaps in 2013?
Saskia Middeldorp (Netherlands)
SoA-17: Vessel wall biology
- Evolutionary origins of endothelium and endothelial heterogeneity
William Aird (USA) - Synthetic microvessels
José Lopez (USA)
SoA-18: Gene therapy
- Update on AVV-mediated gene therapy for haemophilia B
Amit Nathwani (United Kingdom) - Gene therapy for haemophilia: state of the art
Thierry Vandendriessche (Belgium)